MCID: RTC005
MIFTS: 48

Reticulosarcoma malady

Categories: Rare diseases, Cancer diseases, Immune diseases

Aliases & Classifications for Reticulosarcoma

Aliases & Descriptions for Reticulosarcoma:

Name: Reticulosarcoma 12 14 69
Diffuse Large B-Cell Lymphoma 69
Lymphoma, Non-Hodgkin 42
Histiocytic Lymphoma 12
Large-Cell Lymphomas 12
Lymphoma, Large-Cell 50
Large Cell Lymphoma 50
Histiocytic Sarcoma 69
Lymphoma Large Cell 52

Classifications:



Summaries for Reticulosarcoma

MalaCards based summary : Reticulosarcoma, also known as diffuse large b-cell lymphoma, is related to anaplastic large cell lymphoma and lymphoma, non-hodgkin. An important gene associated with Reticulosarcoma is ALK (ALK Receptor Tyrosine Kinase), and among its related pathways/superpathways are Cytokine Signaling in Immune system and NF-kappaB Signaling. The drugs Adcetris and Dexamethasone have been mentioned in the context of this disorder. Affiliated tissues include b cells, thyroid and bone, and related phenotypes are growth/size/body region and endocrine/exocrine gland

Related Diseases for Reticulosarcoma

Diseases related to Reticulosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 74)
id Related Disease Score Top Affiliating Genes
1 anaplastic large cell lymphoma 12.7
2 lymphoma, non-hodgkin 12.6
3 alk-positive anaplastic large cell lymphoma 12.4
4 alk-negative anaplastic large cell lymphoma 12.4
5 primary cutaneous anaplastic large cell lymphoma 12.2
6 lymphoma, large-cell, immunoblastic 12.1
7 intravascular large b-cell lymphoma 11.4
8 primary mediastinal large b-cell lymphoma 11.2
9 reticulum cell sarcoma 11.2
10 malignant glioma 10.2 GZMB TIA1
11 alström syndrome 10.2 GZMB TIA1
12 hinman syndrome 10.2 PAX5 PTPRC
13 skeletal muscle cancer 10.2 GZMB TIA1
14 post-transplant lymphoproliferative disease 10.2 ALK GZMB TIA1
15 tibial adamantinoma 10.2 GZMB TIA1
16 neurofibromatosis 10.2 NPM1 PAX5 PTPRC
17 uterine ligament endometrioid adenocarcinoma 10.2 GZMB PAX5 TIA1
18 superior limbic keratoconjunctivitis 10.2 GZMB TIA1
19 ethmoid sinus inverted papilloma 10.2 BCL6 PTPRC
20 collagen type iii glomerulopathy 10.1 GZMB TIA1
21 fibrosclerosis of breast 10.1 GZMB TIA1
22 estrogen-receptor negative breast cancer 10.1 ALK NPM1 PTPRC TIA1
23 complication after organ transplantation 10.1 ALK MUC1 NPM1
24 macrogyria, pseudobulbar palsy and mental retardation 10.1 ALK GZMB NPM1 TIA1
25 pre-malignant neoplasm 10.1 GZMB TIA1 TNFRSF8
26 lymphosarcoma 10.1
27 subacute delirium 10.1 ALK PAX5 PTPRC TNFRSF8
28 spinal cord intramedullary teratoma 10.1 BCL6 PTPRC TNFRSF8
29 omodysplasia 2 10.1 MUC1 PTPRC TNFRSF8
30 hemophagocytic lymphohistiocytosis 10.1 ALK NPM1 PAX5 TNFRSF8
31 ureter transitional cell carcinoma 10.1 BCL6 PAX5 TNFRSF8
32 ureter small cell carcinoma 10.0 BCL6 PAX5 TNFRSF8
33 coarctation of aorta 10.0 CLU GZMB TIA1 TNFRSF8
34 thyroiditis 10.0
35 penile disease 10.0 ALK BCL6 PTPRC TNFRSF8
36 polydactyly cleft lip palate psychomotor retardation 10.0 BCL6 MUC1 PTPRC
37 lymphoma 10.0
38 cecum adenoma 10.0 ALK BCL2 NPM1
39 rubella panencephalitis 10.0 BCL2 BCL6
40 basal ganglia disease 10.0 BCL6 GZMB PAX5 TNFRSF8
41 ichthyosis, congenital, autosomal recessive 10 9.9 BCL2 BCL6
42 ritscher-schinzel syndrome 9.9 BCL6 CCND3 PAX5
43 hyperaldosteronism, familial, type ii 9.9 B2M GZMB TIA1 TRB
44 malignant pleural solitary fibrous tumor 9.9 ALK CASP3 MUC1
45 sarcoma 9.9
46 cutis laxa, autosomal recessive, type ib 9.8 B2M CASP3 CCND3 PTPRC
47 congenital sucrase-isomaltase deficiency with starch and lactose intolerance 9.8 ALK GZMB MUC1 NPM1 PTPRC TIA1
48 chondrocalcinosis 9.8 BCL2 CLU MUC1
49 hepatitis 9.8
50 dermatomyositis 9.8

Graphical network of the top 20 diseases related to Reticulosarcoma:



Diseases related to Reticulosarcoma

Symptoms & Phenotypes for Reticulosarcoma

MGI Mouse Phenotypes related to Reticulosarcoma:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 10.02 CASP3 CCND3 NPM1 PAX5 PTPRC TIA1
2 endocrine/exocrine gland MP:0005379 9.97 ALK B2M BCL2 BCL6 CASP3 CCND3
3 hematopoietic system MP:0005397 9.96 B2M BCL2 BCL6 CASP3 CCND3 NPM1
4 immune system MP:0005387 9.9 B2M BCL2 BCL6 CASP3 CCND3 CLU
5 neoplasm MP:0002006 9.5 ALK B2M BCL2 CCND3 NPM1 PAX5
6 respiratory system MP:0005388 9.1 ALK BCL2 BCL6 CASP3 CCND3 PTPRC

Drugs & Therapeutics for Reticulosarcoma

FDA approved drugs:

id Drug Name Active Ingredient(s) 17 Company Approval Date
1
Adcetris 17 46 BRENTUXIMAB VEDOTIN Seattle Genetics Approved August 2011

Drugs for Reticulosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 503)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-02-2 5743
2
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 23214-92-8 31703
3
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
4
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 33419-42-0 36462
5
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
6
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 147-94-4 6253
7
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
8
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
9
Gemcitabine Approved Phase 4,Phase 3,Phase 2,Phase 1 95058-81-4 60750
10
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 174722-31-7 10201696
11
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1 3778-73-2 3690
12
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
13
Mechlorethamine Approved Phase 4,Phase 3,Phase 1,Phase 2 51-75-2 4033
14
Thiotepa Approved Phase 4,Phase 2,Phase 3,Phase 1 52-24-4 5453
15
Lenograstim Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 135968-09-1
16
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
17
Vindesine Approved Phase 4 59917-39-4, 53643-48-4 40839
18
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
19
Epirubicin Approved Phase 4,Phase 2 56420-45-2 41867
20
Crizotinib Approved Phase 4,Phase 3,Phase 2,Phase 1 877399-52-5 11626560 10366136 10366137 10366138 10366139 10366140 10366141
21
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 58-05-9 54575, 6560146 143
22
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 59-30-3 6037
23
Doxil Approved June 1999 Phase 4,Phase 3,Phase 2,Phase 1 31703
24
Pirarubicin Investigational Phase 4 72496-41-4
25 Prednisolone acetate Phase 4,Phase 3,Phase 2,Phase 1
26 Dexamethasone acetate Phase 4,Phase 3,Phase 2,Phase 1 1177-87-3
27 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
28 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1
29 Folic Acid Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
30 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1
31 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
32 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
33 Dermatologic Agents Phase 4,Phase 3,Phase 2,Phase 1
34 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
35 Dexamethasone 21-phosphate Phase 4,Phase 3,Phase 2,Phase 1
36 Hormones Phase 4,Phase 3,Phase 2,Phase 1
37 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
38 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
39 Vitamin B Complex Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
40 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
41 Etoposide phosphate Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
42 Immunoglobulins Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
43 Prednisolone hemisuccinate Phase 4,Phase 3,Phase 2,Phase 1
44 Prednisolone phosphate Phase 4,Phase 3,Phase 2,Phase 1
45 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
46 Antibodies, Monoclonal Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
47 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
48 Protein Kinase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
49 Antiemetics Phase 4,Phase 3,Phase 2,Phase 1
50 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 933)
id Name Status NCT ID Phase
1 Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old. Unknown status NCT00429065 Phase 4
2 Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults Completed NCT00199082 Phase 4
3 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4
4 CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma Recruiting NCT01746992 Phase 4
5 CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL Recruiting NCT02533700 Phase 4
6 Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma Active, not recruiting NCT01909934 Phase 4
7 A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib Withdrawn NCT02487316 Phase 4
8 Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma Unknown status NCT00006455 Phase 3
9 Study Comparing the Zevalin Regimen With no Further Treatment in DLBCL Patients Who Are in Complete Remission After CHOP-R Unknown status NCT00322218 Phase 3
10 Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma Unknown status NCT00052936 Phase 3
11 Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00003815 Phase 3
12 Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma Unknown status NCT00028717 Phase 3
13 Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma Unknown status NCT00003337 Phase 3
14 Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma Unknown status NCT00003338 Phase 2, Phase 3
15 Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia Unknown status NCT00445497 Phase 3
16 Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma Unknown status NCT00003423 Phase 3
17 Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00053768 Phase 3
18 High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma Unknown status NCT00003578 Phase 3
19 Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia Unknown status NCT00020865 Phase 3
20 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3
21 Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Unknown status NCT00002989 Phase 3
22 Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma Unknown status NCT00003924 Phase 3
23 A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients Unknown status NCT01303887 Phase 3
24 Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma Completed NCT00059839 Phase 3
25 Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma Completed NCT00052923 Phase 3
26 Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma Completed NCT00002618 Phase 3
27 Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma Completed NCT00566228 Phase 3
28 R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma Completed NCT00137995 Phase 3
29 ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma Completed NCT00169130 Phase 2, Phase 3
30 Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma Completed NCT01014208 Phase 3
31 Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV Completed NCT00286832 Phase 3
32 ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1 Completed NCT00140595 Phase 3
33 R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma Completed NCT00144755 Phase 3
34 Rituxan vs Bexxar When Combined With Carmustine, Etoposide, Cytarabine and Melphalan (BEAM) With Autologous Hematopoietic Stem Cell Transplantation (BMT CTN 0401) Completed NCT00329030 Phase 3
35 Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00012051 Phase 3
36 Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications Completed NCT00799461 Phase 3
37 Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma Completed NCT00002649 Phase 3
38 Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00064116 Phase 3
39 Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation Completed NCT00031668 Phase 3
40 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma Completed NCT00003150 Phase 3
41 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma Completed NCT00003595 Phase 3
42 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma Completed NCT00003215 Phase 3
43 Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00278421 Phase 3
44 Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma Completed NCT00278408 Phase 3
45 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma Completed NCT00005590 Phase 3
46 Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma Completed NCT00004112 Phase 3
47 Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma Completed NCT00002576 Phase 3
48 Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Completed NCT00005867 Phase 3
49 Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma Completed NCT00002565 Phase 3
50 Combination Chemotherapy in Treating Patients With Lymphoma Completed NCT00002835 Phase 3

Search NIH Clinical Center for Reticulosarcoma

Cochrane evidence based reviews: lymphoma, non-hodgkin

Genetic Tests for Reticulosarcoma

Anatomical Context for Reticulosarcoma

MalaCards organs/tissues related to Reticulosarcoma:

39
B Cells, Thyroid, Bone, Liver, Monocytes, Breast, Tonsil

Publications for Reticulosarcoma

Articles related to Reticulosarcoma:

(show top 50) (show all 74)
id Title Authors Year
1
Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice. ( 11426330 )
2001
2
In vitro and in vivo characterisation of low-resistant mouse reticulosarcoma (M5076) sublines obtained after pulse and continuous exposure to cisplatin. ( 8943689 )
1996
3
Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice. ( 2189589 )
1990
4
Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles. ( 3315188 )
1987
5
Primary reticulosarcoma of bone (non-Hodgkin's lymphoma). A study of 12 cases. ( 3503874 )
1987
6
Ultrastructural and freeze fracture localization of multilamellar liposomes containing a lipophilic cisplatin analogue in normal tissues and liver metastases of M5076 reticulosarcoma. ( 3322541 )
1987
7
Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor. ( 3100032 )
1987
8
Round-cell sarcomas of bone and their differential diagnosis (with particular emphasis on Ewing's sarcoma and reticulosarcoma). A study of 233 tumors with optical and electron microscopic techniques. ( 6763672 )
1982
9
Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisation. ( 373920 )
1978
10
Morphology of lymphoreticular tissues in mice with reticulosarcoma. ( 365565 )
1978
11
Chemotherapists' need for uniform and rational nomenclature and classification of common lymphosarcomas and reticulosarcoma (hematosarcomas or non-Hodgkin's lymphomas). ( 373918 )
1978
12
Preliminary results of chemoradiotherapy followed (or not ) by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma: correlation of the results with WHO categorization. ( 370939 )
1978
13
Modifications of macrophage chemotaxis in rats bearing the transplantable tumour reticulosarcoma 'IRE'. ( 335481 )
1977
14
Combination chemotherapy with adriamycine, VM 26, cyclophosphamide and prednisone in lymphosarcoma and reticulosarcoma stage III and IV. ( 326554 )
1977
15
Malignant lymphoma (reticulosarcoma) in bone. ( 334431 )
1977
16
Adult coeliac disease. A case with ulceration, dermatitis herpetiformis and reticulosarcoma. ( 766153 )
1976
17
Pathogenesis of ascites in a murine transplantable reticulosarcoma type A. ( 137595 )
1976
18
Hairy cell leukemia ('leukemic reticuleondotheliosis'), reticulosarcoma, and monocytic leukemia. Cytochemical and ultrastructural investigations. ( 808067 )
1975
19
Microglioma and/or reticulosarcoma of the nervous system. ( 51573 )
1975
20
Reticulosarcoma occurring during long-term hemodialysis. ( 1092500 )
1975
21
The effect of immunostimulation and chemotherapy on the growth of reticulosarcoma in mice. ( 4618487 )
1974
22
Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. II. Reticulosarcoma. (Correlation with the immunity reaction of the cellular type and the clinical status). ( 4573872 )
1973
23
Blastoid lymphocyte transformation assay in malignant tumours of lymphopoietic tissue: in Hodgkin's disease, reticulosarcoma, lymphosarcoma and chronic lymphatic leukaemia. Relationship to the clinical status and to the delayed type of hypersensitivity. ( 4128515 )
1973
24
Reticulosarcoma of the vulva complicating dermatomyositis treated by immunosuppression. ( 4577331 )
1973
25
Reticulosarcoma of vulva complicating azathioprine-treated dermatomyositis. ( 4583173 )
1973
26
Lambda cold agglutinin with anti-A 1 specificity in a patient with reticulosarcoma. ( 4622181 )
1972
27
Cytologic studies of tumors. L. clonal proliferation of four stemlines in three hematopoietic tissues of a patient with reticulosarcoma. ( 4925076 )
1971
28
Reticulosarcoma and amyloid development in BALB/c mice inoculated with syngeneic cells from young and old donors. ( 4941118 )
1971
29
Primary cerebral reticulosarcoma. ( 4913659 )
1970
30
Cytogenetic analysis in two cases of lymphoma. Comparison between lymphosarcoma and reticulosarcoma. ( 4910257 )
1970
31
Reticulosarcoma of the stomach. Report of 13 cases with follow-up results. ( 4931920 )
1970
32
Reticulosarcoma of the caecum. ( 5337477 )
1967
33
Electron microscopic study of tonsillar reticulosarcoma. I. Features of malignancy in tumor cells. ( 4886966 )
1967
34
Electron microscopic study of tonsillar reticulosarcoma. II. Effect of radiation on tumor cells. ( 4886967 )
1967
35
Reticulosarcoma of the eye treated with cyclophosphamide. ( 5336275 )
1966
36
DISSEMINATED HISTOPLASMOSIS FOLLOWING LONG-TERM STEROID THERAPY FOR RETICULOSARCOMA. ( 14331625 )
1965
37
LYMPHOGRAPHY WITH RADIOACTIVE CONTRAST MEDIUM IN LYMPHOSARCOMA AND RETICULOSARCOMA. ( 14247471 )
1965
38
INTESTINAL RETICULOSARCOMA IN IDIOPATHIC STEATORRHOEA. ( 14273509 )
1964
39
ACQUIRED HYPOGAMMAGLOBULINAEMIA COMPLICATED BY RETICULOSARCOMA. ( 14098564 )
1963
40
Case of Mesenteric Reticulosarcoma Associated with Gluten-sensitive Steatorrhoea. ( 20789212 )
1961
41
Malignant tumours of the stomach arising from the lympho-reticular system. A report of 10 cases of lymphosarcoma and reticulosarcoma of the stomach. ( 14492653 )
1961
42
Primary reticulosarcoma of the thyroid gland. ( 13742171 )
1961
43
Reticulosarcoma complicating sarcoidosis. ( 13805580 )
1960
44
Trypan blue concentration and protein composition in sera of rats injected repeatedly with Trypan blue in relation to reticulosis and to reticulosarcoma. ( 13722875 )
1960
45
The mechanical resistance of white blood cells in lymphosarcoma, reticulosarcoma and malignant lymphogranuloma: a contribution to the differential diagnosis and to the knowledge of the biologic behaviour of leukocytes in human pathology. ( 13798549 )
1959
46
Reticulosarcoma. ( 13653789 )
1959
47
[A case of "malignant granuloma of the nose"; reticulosarcoma]. ( 13670636 )
1959
48
Reticulosarcoma of both breasts. ( 13835234 )
1959
49
Perforating reticulosarcoma of the jejunum. ( 14420016 )
1959
50
Studies on the therapy of reticulosarcoma(-tosis) with actinomycin. ( 14445951 )
1959

Variations for Reticulosarcoma

Expression for Reticulosarcoma

Search GEO for disease gene expression data for Reticulosarcoma.

Pathways for Reticulosarcoma

GO Terms for Reticulosarcoma

Cellular components related to Reticulosarcoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 focal adhesion GO:0005925 8.92 B2M CCND3 NPM1 PTPRC

Biological processes related to Reticulosarcoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 negative regulation of cell proliferation GO:0008285 9.76 BCL2 BCL6 NPM1 TNFRSF8
2 apoptotic process GO:0006915 9.55 BCL2 CASP3 CLU GZMB TIA1
3 positive regulation of NF-kappaB transcription factor activity GO:0051092 9.54 ALK CLU NPM1
4 release of cytochrome c from mitochondria GO:0001836 9.43 BCL2 CLU
5 regulation of cell cycle GO:0051726 9.43 BCL2 CCND3 PTPRC
6 B cell homeostasis GO:0001782 9.4 BCL2 CASP3
7 positive regulation of receptor-mediated endocytosis GO:0048260 9.32 B2M CLU
8 cell morphogenesis GO:0000902 9.13 BCL2 BCL6 CLU
9 positive regulation of B cell proliferation GO:0030890 8.8 BCL2 BCL6 PTPRC

Sources for Reticulosarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....